Trending...
- Rhealize Strategic Talent Advisory Co-Founder Dona Baker to Speak at DisruptHR YEG 15.0 in Edmonton on Hiring Innovation - 116
- PlanetAI Nature Space (PNS), certificadora Europea, lanza su plataforma EUDR-PNS Ready basada en IA, satélites y trazabilidad blockchain - 103
- Architect of Neurodiversity Will Lead the First U.S. Team of Autistic Children to the "Genius Cup" in Hiroshima, Japan, in 2027
This Approval Allows MedWand to Enhance Efficiency, Convenience, and Access to Care in Thailand
RANCHO SANTA MARGARITA, Calif. - Michimich -- MedWand Solutions, Inc., the ultimate healthcare solution and a pioneer in telehealth technology, is pleased to announce its recent regulatory clearance in Thailand. This latest approval allows MedWand to empower a broader spectrum of clinicians and healthcare providers, enabling them to elevate care standards and grant easier access to healthcare services.
"The regulatory clearance in Thailand reflects our dedication to making comprehensive remote healthcare services accessible worldwide," shared MedWand Senior Director of International Business Development, Stuart English. "We are thrilled to bring MedWand to Thailand, addressing healthcare needs and creating new opportunities for collaboration with international partners."
More on Michimich.com
MedWand is the ultimate healthcare solution, seamlessly integrating traditional tools and Bluetooth connectivity for vitals capture and remote patient evaluations to enhance efficiency, convenience, and access to care. Following its FDA clearance and product launch in the United States in 2022, MedWand has gained significant traction with major US health systems, telehealth companies, large private practices, and employers.
"Following thorough research, we have identified the MedWand multi-sensor vitals capture device, together with the VirtualCare telemedicine platform, as the pivotal components essential for revolutionizing telemedicine services. This combination is poised to facilitate advanced clinical care accessible to patients regardless of their location, eliminating the necessity for hospital visits," commented Dr. Supornchai Kongpatanakul, President of Kitmeechai Trading Co., Ltd.
More on Michimich.com
The device's versatility and ease of use make it a valuable asset for both healthcare professionals and patients. Transforming the traditional understanding of telehealth, MedWand combines multiple vitals sensors into one, handheld, lightweight device. Data collected can include core temperature, blood oxygen saturation, and pulse rate, heart, lung and abdominal auscultations, electrocardiogram*, and high definition otoscopic, oropharynx, and dermatoscopic exam images. Through approved 3rd party Bluetooth peripherals, MedWand can also seamlessly capture blood pressure, glucometer, spirometry, and weight data.
For more information on MedWand visit www.medwand.com. To schedule a private demonstration or to request a formal quotation please contact MedWand at https://www.medwandhealth.com/contact.
*Electrocardiogram feature is currently awaiting US FDA 510(k) clearance.
"The regulatory clearance in Thailand reflects our dedication to making comprehensive remote healthcare services accessible worldwide," shared MedWand Senior Director of International Business Development, Stuart English. "We are thrilled to bring MedWand to Thailand, addressing healthcare needs and creating new opportunities for collaboration with international partners."
More on Michimich.com
- Custom Glass Manufacturer in Novi Explains Channels and Clips for Shower Doors
- Ann Arbor Chiropractor Explains how Specific Structural Care Helps Arm & Shoulder Pain
- Alumi-Span Docks Celebrates 70 Years of Business, Highlights the Advantages of Anodized Aluminum
- Special Alert! Highly Undervalued Stock: $317M Revenue in 2025 for Telecom Leader IQSTEL, Inc. (N A S D A Q: IQST)
- Igniting High-Growth Transformation With Launch of XMax AI Subsidiary, Leveraging Global Furniture Dominance to Enter Explosive AI Markets: XMax Inc
MedWand is the ultimate healthcare solution, seamlessly integrating traditional tools and Bluetooth connectivity for vitals capture and remote patient evaluations to enhance efficiency, convenience, and access to care. Following its FDA clearance and product launch in the United States in 2022, MedWand has gained significant traction with major US health systems, telehealth companies, large private practices, and employers.
"Following thorough research, we have identified the MedWand multi-sensor vitals capture device, together with the VirtualCare telemedicine platform, as the pivotal components essential for revolutionizing telemedicine services. This combination is poised to facilitate advanced clinical care accessible to patients regardless of their location, eliminating the necessity for hospital visits," commented Dr. Supornchai Kongpatanakul, President of Kitmeechai Trading Co., Ltd.
More on Michimich.com
- Acuvance Earns 2026 Great Place to Work® Certification
- As Global Tensions Rise, Demand Grows for Private Spaces to Process Thoughts and Speak Freely Online
- Cryptsoft demonstrates Hybrid-PQC Authentication Token use for quantum-safe systems and infrastructure
- Expert Law Attorneys' Top Law Firms to Know: March 2026
- Green Office Partner Strengthens Global Operations with Mexico-Based DigitalVAAR Partnership
The device's versatility and ease of use make it a valuable asset for both healthcare professionals and patients. Transforming the traditional understanding of telehealth, MedWand combines multiple vitals sensors into one, handheld, lightweight device. Data collected can include core temperature, blood oxygen saturation, and pulse rate, heart, lung and abdominal auscultations, electrocardiogram*, and high definition otoscopic, oropharynx, and dermatoscopic exam images. Through approved 3rd party Bluetooth peripherals, MedWand can also seamlessly capture blood pressure, glucometer, spirometry, and weight data.
For more information on MedWand visit www.medwand.com. To schedule a private demonstration or to request a formal quotation please contact MedWand at https://www.medwandhealth.com/contact.
*Electrocardiogram feature is currently awaiting US FDA 510(k) clearance.
Source: MedWand Solutions
Filed Under: Health
0 Comments
Latest on Michimich.com
- MAG Magna Corp Targets Trillion-Dollar Opportunity by Tokenizing Rare Earth Assets Critical to AI, EVs, & Defense: MAG Magna Corp.: Stock Symbol: MGNC
- SnapTax Launches AI-Powered Tax Planning Platform for Freelancers and 1099 Workers — Now Free for 90 Days
- Hillside Terrace Highlights How Assisted Living Supports Cognitive Health Before Memory Care
- Congressional Roundtable Exposes Mental Health Crisis: More Spending and Treatment, Worse Results – CCHR Demands Accountability
- Ann Arbor Law Firm Advises Fiduciaries on Estate and Trust Income Tax Obligations
- Michigan Driving Law Updates in 2026 Increase Importance of License Reinstatement Representation
- ArborMotion Offers Comprehensive European Auto Repair Services in Ann Arbor
- Attorney Joseph C. Kreps Files Lawsuit to Stop Alabama State Board of Pharmacy's Unlawful "Revenue-First" Rulemaking
- NAIDOC Week Australia 2026 | 50 Years Deadly - Celebrates Culture, Resilience, and Global Connection
- PlanetAI Nature Space (PNS), certificadora Europea, lanza su plataforma EUDR-PNS Ready basada en IA, satélites y trazabilidad blockchain
- Pintsch North America to Exhibit Advanced Rail Signaling Technologies at 2026 ASLRRA Conference
- Compressed Gas Technologies, INC. Highlights the Benefits of On-Site N2 Generation
- Mussio Painting Highlights the Importance of Preparation and Quality Materials
- Bavarian Blast Waterpark Nominated for "Best Indoor Waterpark in the Nation" by USA Today 10Best
- Rhealize Strategic Talent Advisory Co-Founder Dona Baker to Speak at DisruptHR YEG 15.0 in Edmonton on Hiring Innovation
- Instant IP Teams: Bringing Enterprise-Grade Collaboration to IP Protection at the Speed of Thought
- UK Financial Ltd Confirms CATEX Exchange Integration of SMPRA and LTNS 1 Ahead of Compliance-Based Trading Activation
- Ashikaga Flower Park's "Great Wisteria Festival 2026"
- Architect of Neurodiversity Will Lead the First U.S. Team of Autistic Children to the "Genius Cup" in Hiroshima, Japan, in 2027
- Deborah E. Jones Introduces Emotional Sovereignty, a Powerful New Book on Emotional Mastery, Resilience, and Intentional Living
